Across TCGA pan-cancer cohorts, RC3H1-IT1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated RC3H1-IT1 data layer.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where higher RC3H1-IT1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RC3H1-IT1 expression acts as an unfavorable survival marker, although some lineages such as BRCA and LAML show a favorable association.
LUSC, KIRC, and UVM are the cancer types where RC3H1-IT1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.